{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:46:51Z","timestamp":1792684011093,"version":"4.5.0"},"reference-count":10,"publisher":"American Society of Hematology","issue":"17","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10,22]]},"DOI":"10.1182\/blood.2026035302","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:32:08Z","timestamp":1792683128000},"page":"2093-2094","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["DEK: once a translocation partner, now an oncogenic effector"],"prefix":"10.1182","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8209-5645","authenticated-orcid":false,"given":"William","family":"Grey","sequence":"first","affiliation":[{"name":"University of York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"17","key":"2026102211320363500_bib1","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1182\/blood.2025032710","article-title":"Phosphorylated DEK sustains leukemia stem cells by enabling PBX3-driven transcriptional reprogramming","volume":"148","author":"Lei","year":"2026","journal-title":"Blood"},{"issue":"5","key":"2026102211320363500_bib2","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"issue":"5782","key":"2026102211320363500_bib3","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1126\/science.1128659","article-title":"Intron removal requires proofreading of U2AF\/3\u2019 splice site recognition by DEK","volume":"312","author":"Soares","year":"2006","journal-title":"Science"},{"issue":"5","key":"2026102211320363500_bib4","doi-asserted-by":"crossref","first-page":"e20201974","DOI":"10.1084\/jem.20201974","article-title":"Nuclear DEK preserves hematopoietic stem cells potential via NCoR1\/HDAC3-Akt1\/2-mTOR axis","volume":"218","author":"Chen","year":"2021","journal-title":"J Exp Med"},{"issue":"8","key":"2026102211320363500_bib5","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1182\/blood-2012-07-442004","article-title":"PBX3 is an important cofactor of HOXA9 in leukemogenesis","volume":"121","author":"Li","year":"2013","journal-title":"Blood"},{"issue":"3","key":"2026102211320363500_bib6","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1158\/1078-0432.CCR-06-1602","article-title":"Protein kinase CK2alpha as an unfavorable prognostic marker and novel therapeutic target in acute myeloid leukemia","volume":"13","author":"Kim","year":"2007","journal-title":"Clin Cancer Res"},{"key":"2026102211320363500_bib7","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1756-8722-6-78","article-title":"Inhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicity","volume":"6","author":"Quotti Tubi","year":"2013","journal-title":"J Hematol Oncol"},{"issue":"8","key":"2026102211320363500_bib8","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1182\/blood-2010-07-298802","article-title":"GABP transcription factor is required for myeloid differentiation, in part, through its control of Gfi-1 expression","volume":"118","author":"Yang","year":"2011","journal-title":"Blood"},{"issue":"3","key":"2026102211320363500_bib9","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/hep.32804","article-title":"Silmitasertib plus gemcitabine and cisplatin first-line therapy in locally advanced\/metastatic cholangiocarcinoma: a phase 1b\/2 study","volume":"77","author":"Borad","year":"2023","journal-title":"Hepatology"},{"issue":"3","key":"2026102211320363500_bib10","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3324\/haematol.2022.281668","article-title":"Inhibition of casein kinase 2 sensitizes mantle cell lymphoma to venetoclax through MCL-1 downregulation","volume":"108","author":"Thus","year":"2023","journal-title":"Haematologica"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/148\/17\/2093\/2595400\/blood_bld-2026-035302-c-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/148\/17\/2093\/2595400\/blood_bld-2026-035302-c-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:32:11Z","timestamp":1792683131000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/148\/17\/2093\/571563\/DEK-once-a-translocation-partner-now-an-oncogenic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":10,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2026,10,22]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2026035302","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10,22]]},"published":{"date-parts":[[2026,10,22]]}}}